{"DataElement":{"publicId":"7038770","version":"1","preferredName":"Invasive Breast Carcinoma Diagnosis Type","preferredDefinition":"The description of the type of invasive breast disease present.","longName":"MHIBDXTP","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"7038768","version":"1","preferredName":"Medical History Domain Invasive Breast Carcinoma Diagnosis","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history._A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"6401571v1.0:7038766v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6401571","version":"1","preferredName":"Medical History Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.","longName":"C49603","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medical History Domain","conceptCode":"C49603","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"738FDBAB-92FD-1DB7-E053-F662850A27F3","latestVersionIndicator":"Yes","beginDate":"2018-08-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-16","modifiedBy":"ONEDATA","dateModified":"2018-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7038766","version":"1","preferredName":"Invasive Breast Carcinoma Diagnosis","preferredDefinition":"A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"C9245:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Carcinoma","conceptCode":"C9245","definition":"A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96521C19-1D94-3A85-E053-F662850AE750","latestVersionIndicator":"Yes","beginDate":"2019-11-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"96521C19-1DA5-3A85-E053-F662850AE750","latestVersionIndicator":"Yes","beginDate":"2019-11-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"KUMMEROA","dateModified":"2020-06-17","changeDescription":"Released. AK 2020-6-10; Created for CDSIC aligned NCI Standard CRFs. ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7038769","version":"1","preferredName":"Invasive Breast Carcinoma Type","preferredDefinition":"Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host._One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest._Clinical, laboratory or molecular evidence, or absence of evidence of disease._The result of an action._Something distinguishable as an identifiable class based on common qualities.","longName":"INV_BRST_CRC_TYP","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Acinic cell carcinoma","valueDescription":"Acinic Cell Breast Carcinoma","ValueMeaning":{"publicId":"5943824","version":"1","preferredName":"Acinic Cell Breast Carcinoma","longName":"5943824","preferredDefinition":"A breast adenocarcinoma characterized by the presence of serous (acinic cell) differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Acinic Cell Carcinoma","conceptCode":"C40367","definition":"A breast adenocarcinoma characterized by the presence of serous (acinic cell) differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57D6250A-9095-45A3-E053-F662850A2287","latestVersionIndicator":"Yes","beginDate":"2017-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FD06-0C22-E053-F662850AD16E","beginDate":"2017-08-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Adenocarcinoma with spindle cell metaplasia","valueDescription":"Breast Adenocarcinoma with Spindle Cell Metaplasia","ValueMeaning":{"publicId":"2577120","version":"1","preferredName":"Breast Adenocarcinoma with Spindle Cell Metaplasia","longName":"2577120","preferredDefinition":"An invasive adenocarcinoma of the breast usually affecting post-menopausal women, characterized by extensive spindle cell metaplasia of the neoplastic glandular cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Adenocarcinoma with Spindle Cell Metaplasia","conceptCode":"C40360","definition":"An invasive adenocarcinoma of the breast usually affecting post-menopausal women, characterized by extensive spindle cell metaplasia of the neoplastic glandular cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA4D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FD10-0C22-E053-F662850AD16E","beginDate":"2017-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Adenoid cystic carcinoma","valueDescription":"Adenoid Cystic Breast Carcinoma","ValueMeaning":{"publicId":"2581151","version":"1","preferredName":"Adenoid Cystic Breast Carcinoma","longName":"2581151","preferredDefinition":"An adenoid cystic carcinoma primarily involving the breast. Three morphologic patterns are seen: cribriform, trabecular, and solid. The prognosis is excellent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Adenoid Cystic Carcinoma","conceptCode":"C5130","definition":"An adenoid cystic carcinoma primarily involving the breast.  Three morphologic patterns are seen: cribriform, trabecular, and solid.  The prognosis is excellent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A0C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FD1A-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Adenosquamous carcinoma","valueDescription":"Adenosquamous Breast Carcinoma","ValueMeaning":{"publicId":"2581226","version":"1","preferredName":"Adenosquamous Breast Carcinoma","longName":"2581226","preferredDefinition":"An invasive breast carcinoma characterized by the presence of tubular and glandular neoplastic cell structures, admixed with islands of neoplastic cells showing squamous differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Adenosquamous Carcinoma","conceptCode":"C40361","definition":"An invasive breast carcinoma characterized by the presence of tubular and glandular neoplastic cell structures, admixed with islands of neoplastic cells showing squamous differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A57-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FD24-0C22-E053-F662850AD16E","beginDate":"2017-08-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Angiosarcoma","valueDescription":"Breast Angiosarcoma","ValueMeaning":{"publicId":"5914157","version":"1","preferredName":"Breast Angiosarcoma","longName":"5914157","preferredDefinition":"A malignant vascular neoplasm arising from the breast.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Angiosarcoma","conceptCode":"C5184","definition":"A malignant vascular neoplasm arising from the breast.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54AE1D2D-E0BE-3CB9-E053-F662850ACAEF","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FD2E-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Apocrine carcinoma","valueDescription":"Apocrine Breast Carcinoma","ValueMeaning":{"publicId":"2577122","version":"1","preferredName":"Apocrine Breast Carcinoma","longName":"2577122","preferredDefinition":"An adenocarcinoma of the breast characterized by the presence of two intermingled cellular components: cells with abundant granular, eosinophilic cytoplasm, and cells with abundant cytoplasm containing fine empty vacuoles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Apocrine Carcinoma","conceptCode":"C5141","definition":"An adenocarcinoma of the breast characterized by the presence of two intermingled cellular components: cells with abundant granular, eosinophilic cytoplasm, and cells with abundant cytoplasm containing fine empty vacuoles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA4F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FD38-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Axillary nodal with metastatic carcinoma","valueDescription":"Axillary Lymph Node With Metastatic Carcinoma","ValueMeaning":{"publicId":"5914296","version":"1","preferredName":"Axillary Lymph Node With Metastatic Carcinoma","longName":"5914296","preferredDefinition":"One of approximately 20-30 lymph nodes in chain formation that traverse the concavity of the underarm to the clavicle.: Used to indicate the presence of something or someone.: A carcinoma which has spread from the original site of growth to another anatomic site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Axillary Lymph Node","conceptCode":"C12904","definition":"One of approximately 20-30 lymph nodes in chain formation that traverse the concavity of the underarm to the clavicle.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Metastatic Carcinoma","conceptCode":"C3482","definition":"Carcinoma that has spread from its original site of growth to other anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B1EEE3-C903-0E6F-E053-F662850A3AD8","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FD42-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Axillary node with lymphoma","valueDescription":"Axillary Lymph Node With Lymphoma","ValueMeaning":{"publicId":"5914297","version":"1","preferredName":"Axillary Lymph Node With Lymphoma","longName":"5914297","preferredDefinition":"One of approximately 20-30 lymph nodes in chain formation that traverse the concavity of the underarm to the clavicle.: Used to indicate the presence of something or someone.: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Axillary Lymph Node","conceptCode":"C12904","definition":"One of approximately 20-30 lymph nodes in chain formation that traverse the concavity of the underarm to the clavicle.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B1EEE3-C92C-0E6F-E053-F662850A3AD8","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FD4C-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Basal cell carcinoma of the nipple","valueDescription":"Nipple Basal Cell Carcinoma","ValueMeaning":{"publicId":"5914295","version":"1","preferredName":"Nipple Basal Cell Carcinoma","longName":"5914295","preferredDefinition":"The pigmented protuberance on the surface of the breast through which milk is drawn from the breast.: The most frequently seen skin cancer. It arises from basal cells of the epidermis and pilosebaceous units. Clinically it is divided into the following types: nodular, ulcerative, superficial, multicentric, erythematous, and sclerosing or morphea-like. More than 95% of these carcinomas occur in patients over 40. They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck and the remaining 15% on the trunk and extremities. Basal cell carcinoma usually grows in a slow and indolent fashion. However, if untreated, the tumor may invade the subcutaneous fat, skeletal muscle and bone. Distant metastases are rare. Excision, curettage and irradiation cure most basal cell carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nipple","conceptCode":"C12299","definition":"The pigmented protuberance on the surface of the breast through which milk is drawn from the breast.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Skin Basal Cell Carcinoma","conceptCode":"C2921","definition":"The most frequently seen skin cancer. It arises from basal cells of the epidermis and pilosebaceous units. Clinically it is divided into the following types: nodular, ulcerative, superficial, multicentric, erythematous, and sclerosing or morphea-like. More than 95% of these carcinomas occur in patients over 40. They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck and the remaining 15% on the trunk and extremities. Basal cell carcinoma usually grows in a slow and indolent fashion. However, if untreated, the tumor may invade the subcutaneous fat, skeletal muscle and bone. Distant metastases are rare. Excision, curettage and irradiation cure most basal cell carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B1EEE3-C8DC-0E6F-E053-F662850A3AD8","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FD56-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Carcinoma in situ NOS","valueDescription":"Breast Carcinoma In Situ None Other Specified","ValueMeaning":{"publicId":"5937349","version":"1","preferredName":"Breast Carcinoma In Situ None Other Specified","longName":"5937349","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.: A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.: No person or thing, nobody, not any.: Different than the one(s) previously specified or mentioned.: Clearly and explicitly stated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Carcinoma In Situ","conceptCode":"C2917","definition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specified","conceptCode":"C38024","definition":"Clearly and explicitly stated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5775E2C9-4CDC-4264-E053-F662850A255D","latestVersionIndicator":"Yes","beginDate":"2017-08-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FD60-0C22-E053-F662850AD16E","beginDate":"2017-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Carcinoma with cartilaginous metaplasia","valueDescription":"Breast Carcinoma with Chondroid Metaplasia","ValueMeaning":{"publicId":"5945709","version":"1","preferredName":"Breast Carcinoma with Chondroid Metaplasia","longName":"5945709","preferredDefinition":"An invasive carcinoma of the breast showing differentiation towards cartilaginous structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma with Chondroid Metaplasia","conceptCode":"C47847","definition":"An invasive carcinoma of the breast showing differentiation towards cartilaginous structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57F8F28F-675F-1DD3-E053-F662850A4FC7","latestVersionIndicator":"Yes","beginDate":"2017-08-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FD6A-0C22-E053-F662850AD16E","beginDate":"2017-08-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Carcinoma with choriocarcinomatous features","valueDescription":"Breast Carcinoma with Choriocarcinomatous Features","ValueMeaning":{"publicId":"5943818","version":"1","preferredName":"Breast Carcinoma with Choriocarcinomatous Features","longName":"5943818","preferredDefinition":"An invasive ductal breast carcinoma, not otherwise specified, characterized by increased levels of human beta-chorionic gonadotropin in the serum.  Morphologic evidence of choriocarcinomatous differentiation is rare.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma with Choriocarcinomatous Features","conceptCode":"C40350","definition":"An invasive ductal breast carcinoma, not otherwise specified, characterized by increased levels of human beta-chorionic gonadotropin in the serum.  Morphologic evidence of choriocarcinomatous differentiation is rare.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57D6250A-8FE9-45A3-E053-F662850A2287","latestVersionIndicator":"Yes","beginDate":"2017-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FD74-0C22-E053-F662850AD16E","beginDate":"2017-08-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Carcinoma with endocrine differentiation","valueDescription":"Breast Carcinoma with Endocrine Differentiation","ValueMeaning":{"publicId":"5914155","version":"1","preferredName":"Breast Carcinoma with Endocrine Differentiation","longName":"5914155","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.: Used to indicate the presence of something or someone.: Collective designation for those tissues capable of secreting hormones.: In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Endocrine","conceptCode":"C41064","definition":"Collective designation for those tissues capable of secreting hormones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cellular Differentiation","conceptCode":"C18314","definition":"In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54AE1D2D-E087-3CB9-E053-F662850ACAEF","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FD7E-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Carcinoma with melanotic features","valueDescription":"Breast Carcinoma with Melanotic Features","ValueMeaning":{"publicId":"5943816","version":"1","preferredName":"Breast Carcinoma with Melanotic Features","longName":"5943816","preferredDefinition":"A very rare primary malignant tumor of the breast, characterized by an invasive breast carcinoma that co-exists with a melanoma component.  The vast majority of melanotic tumors that affect the breast are metastatic melanomas that originate in extra-mammary sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma with Melanotic Features","conceptCode":"C40351","definition":"A very rare primary malignant tumor of the breast, characterized by an invasive breast carcinoma that co-exists with a melanoma component.  The vast majority of melanotic tumors that affect the breast are metastatic melanomas that originate in extra-mammary sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57D6250A-8FAE-45A3-E053-F662850A2287","latestVersionIndicator":"Yes","beginDate":"2017-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FD88-0C22-E053-F662850AD16E","beginDate":"2017-08-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Carcinoma with neuroendocrine differentiation","valueDescription":"Breast Carcinoma With Neuroendocrine Differentiation","ValueMeaning":{"publicId":"5943823","version":"1","preferredName":"Breast Carcinoma With Neuroendocrine Differentiation","longName":"5943823","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.: Used to indicate the presence of something or someone.: A morphological appearance characteristic of invasive carcinomas in which there is focal or extensive transformation (metaplasia) of nests of malignant epithelial cells into cells which resemble neurosecretory cells morphologically, immunohistochemically, and by electron microscopy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neuroendocrine Differentiation","conceptCode":"C43574","definition":"A finding in a tissue sample indicating the presence of epithelial cells that express neuroendocrine markers by immunohistochemistry (e.g., chromogranin A and neuron-specific enolase) and/or neurosecretory granules by electron microscopy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57D6250A-905D-45A3-E053-F662850A2287","latestVersionIndicator":"Yes","beginDate":"2017-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FD92-0C22-E053-F662850AD16E","beginDate":"2017-08-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Carcinoma with osteoclast like stromal giant cells","valueDescription":"Breast Carcinoma with Osteoclastic Giant Cells","ValueMeaning":{"publicId":"3669462","version":"1","preferredName":"Breast Carcinoma with Osteoclastic Giant Cells","longName":"3669462","preferredDefinition":"An invasive breast adenocarcinoma characterised by the presence of non-neoplastic stromal osteoclastic giant cells.  The carcinomatous component is usually an invasive ductal carcinoma, although all other breast adenocarcinoma subtypes have also been described.  The prognosis depends on the characteristics of the adenocarcinomatous component, and is not related to the presence of the giant cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma with Osteoclast-Like Stromal Giant Cells","conceptCode":"C40349","definition":"An invasive breast adenocarcinoma characterised by the presence of non-neoplastic stromal osteoclastic giant cells.  The carcinomatous component is usually an invasive ductal carcinoma, although all other breast adenocarcinoma subtypes have also been described.  The prognosis depends on the characteristics of the adenocarcinomatous component, and is not related to the presence of the giant cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-78CB-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FD9C-0C22-E053-F662850AD16E","beginDate":"2017-08-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Ductal carcinoma","valueDescription":"Ductal Breast Carcinoma","ValueMeaning":{"publicId":"2838039","version":"1","preferredName":"Ductal Breast Carcinoma","longName":"2838039","preferredDefinition":"A carcinoma arising from the ducts.  While ductal carcinomas can arise at other sites, this term is universally used to refer to carcinomas of the breast.  Ductal carcinomas account for about two thirds of all breast cancers.  Two types of ductal carcinomas have been described: Ductal carcinoma in situ (DCIS) and invasive ductal carcinoma, not otherwise specified.  The latter often spreads to the axillary lymph nodes and other anatomic sites.  The two forms of ductal carcinoma often coexist.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma","conceptCode":"C4017","definition":"A breast carcinoma arising from the ducts.  While ductal carcinomas can arise at other sites, this term is universally used to refer to carcinomas of the breast. Ductal carcinomas account for about two thirds of all breast cancers. Two types of ductal carcinomas have been described: ductal carcinoma in situ (DCIS) and invasive breast carcinoma of no special type. The latter often spreads to the axillary lymph nodes and other anatomic sites. The two forms of ductal carcinoma often coexist.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62837FF7-84E7-6F46-E040-BB89AD433964","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FDA6-0C22-E053-F662850AD16E","beginDate":"2017-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Ductal carcinoma in situ, comedo type","valueDescription":"High Grade Ductal Breast Carcinoma In Situ","ValueMeaning":{"publicId":"3249018","version":"1","preferredName":"High Grade Ductal Breast Carcinoma In Situ","longName":"3249018","preferredDefinition":"A ductal carcinoma in situ characterized by the presence of neoplastic cells with severe dysplasia and the formation of micropapillary, cribriform, or solid patterns. The nuclei show marked pleomorphism and have prominent nucleoli. Mitotic activity is usually present. There is comedo-type of necrosis present in the ducts. The necrotic debris is surrounded by pleomorphic malignant cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ, High Grade","conceptCode":"C7949","definition":"Breast ductal carcinoma in situ characterized by the presence of neoplastic cells with severe dysplasia and the formation of micropapillary, cribriform, or solid patterns. The nuclei show marked pleomorphism and have prominent nucleoli. Mitotic activity is usually present. There is comedo-type of necrosis present in the ducts. The necrotic debris is surrounded by pleomorphic malignant cells.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-15EE-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FDB0-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Ductal carcinoma in situ, cribiform type","valueDescription":"Intraductal Cribriform Breast Adenocarcinoma","ValueMeaning":{"publicId":"3249020","version":"1","preferredName":"Intraductal Cribriform Breast Adenocarcinoma","longName":"3249020","preferredDefinition":"A ductal carcinoma in situ of the breast characterized by the presence of a cribriform architectural pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ, Cribriform Pattern","conceptCode":"C5138","definition":"Breast ductal carcinoma in situ characterized by the presence of a cribriform architectural pattern.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-1614-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FDBA-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Ductal carcinoma in situ, micropapillary type","valueDescription":"Intraductal Micropapillary Breast Carcinoma","ValueMeaning":{"publicId":"3249012","version":"1","preferredName":"Intraductal Micropapillary Breast Carcinoma","longName":"3249012","preferredDefinition":"An intraductal papillary carcinoma in which the neoplastic epithelial cells are arranged in micropapillary patterns.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Micropapillary Ductal Carcinoma In Situ","conceptCode":"C5139","definition":"Breast ductal carcinoma in situ characterized by the presence of neoplastic epithelial cells arranged in micropapillary patterns.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-157C-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FDC4-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Ductal carcinoma in situ, solid type","valueDescription":"Ductal Breast Carcinoma In Situ, Solid Type","ValueMeaning":{"publicId":"3249008","version":"1","preferredName":"Ductal Breast Carcinoma In Situ, Solid Type","longName":"3249008","preferredDefinition":"A ductal carcinoma in situ of the breast in which the tumor cells fill the ductal spaces as solid sheets.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ, Solid Type","conceptCode":"C66933","definition":"Breast ductal carcinoma in situ in which the tumor cells fill the ductal spaces as solid sheets.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-1530-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FDCE-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Fibrosarcoma","valueDescription":"Breast Fibrosarcoma","ValueMeaning":{"publicId":"5914160","version":"1","preferredName":"Breast Fibrosarcoma","longName":"5914160","preferredDefinition":"A usually aggressive malignant neoplasm arising from the breast.  It is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation in a herringbone growth pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Fibrosarcoma","conceptCode":"C5185","definition":"A usually aggressive malignant neoplasm arising from the breast.  It is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation in a herringbone growth pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54AEA393-9ED5-58A2-E053-F662850AE86A","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FDD8-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Glycogen-rich carcinoma","valueDescription":"Glycogen-Rich, Clear Cell Breast Carcinoma","ValueMeaning":{"publicId":"5340876","version":"1","preferredName":"Glycogen-Rich, Clear Cell Breast Carcinoma","longName":"5340876","preferredDefinition":"An uncommon, usually aggressive adenocarcinoma of the breast characterized by the presence of clear cells that contain glycogen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glycogen-Rich, Clear Cell Breast Carcinoma","conceptCode":"C40368","definition":"An uncommon, usually aggressive adenocarcinoma of the breast characterized by the presence of clear cells that contain glycogen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"375CD547-5930-BFE6-E050-BB89AD436459","latestVersionIndicator":"Yes","beginDate":"2016-07-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-07-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FDE2-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Hemangiopericytoma","valueDescription":"Breast Hemangiopericytoma","ValueMeaning":{"publicId":"5914171","version":"1","preferredName":"Breast Hemangiopericytoma","longName":"5914171","preferredDefinition":"A hemangiopericytoma arising from the breast.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Hemangiopericytoma","conceptCode":"C40396","definition":"A hemangiopericytoma arising from the breast.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54AF106E-47E0-58A6-E053-F662850A0031","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FDEC-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Hodgkin's lymphoma","valueDescription":"Breast Hodgkin Lymphoma","ValueMeaning":{"publicId":"5914447","version":"1","preferredName":"Breast Hodgkin Lymphoma","longName":"5914447","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.: A lymphoma, previously known as Hodgkin's disease, characterized by the presence of large tumor cells in an abundant admixture of nonneoplastic cells. There are two distinct subtypes: nodular lymphocyte predominant Hodgkin lymphoma and classical Hodgkin lymphoma. Hodgkin lymphoma involves primarily lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hodgkin Lymphoma","conceptCode":"C9357","definition":"A lymphoma characterized by the presence of relatively few malignant cells called Reed-Sternberg cells and mononuclear Hodgkin cells that are admixed with nonneoplastic inflammatory cells. The malignant cells have a distinctive immunophenotype; they are positive for CD30 and CD15 and negative for CD3, CD20, and CD45.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B403C3-8B8D-6E80-E053-F662850A461A","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FDF6-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Inflammatory carcinoma","valueDescription":"Inflammatory Breast Carcinoma","ValueMeaning":{"publicId":"2558969","version":"1","preferredName":"Inflammatory Breast Carcinoma","longName":"2558969","preferredDefinition":"An advanced, invasive breast adenocarcinoma characterized by the presence of distinct changes in the overlying skin. These changes include diffuse erythema, edema, peau d'orange (skin of an orange) appearance, tenderness, induration, warmth, enlargement, and in some cases a palpable mass. The skin changes are the consequence of lymphatic obstruction from the underlying invasive breast adenocarcinoma. Microscopically, the dermal lymphatics show prominent infiltration by malignant cells. The invasive breast adenocarcinoma is usually of ductal, NOS type. There is not significant inflammatory cell infiltrate present, despite the name of this carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Inflammatory Carcinoma","conceptCode":"C4001","definition":"An advanced, invasive breast adenocarcinoma characterized by the presence of distinct changes in the overlying skin. These changes include diffuse erythema, edema, peau d'orange (skin of an orange) appearance, tenderness, induration, warmth, enlargement, and in some cases a palpable mass. The skin changes are the consequence of lymphatic obstruction from the underlying invasive breast adenocarcinoma. Microscopically, the dermal lymphatics show prominent infiltration by malignant cells. The invasive breast adenocarcinoma is usually of ductal, NOS type. There is not significant inflammatory cell infiltrate present, despite the name of this carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B366-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"TAYLORT","dateModified":"2017-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FE00-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Intracystic papillary carcinoma (may be either invasive or DCIS)","valueDescription":"Intracystic Papillary Breast Carcinoma Invasive Or Ductal Breast Carcinoma In Situ","ValueMeaning":{"publicId":"5914698","version":"1","preferredName":"Intracystic Papillary Breast Carcinoma Invasive Or Ductal Breast Carcinoma In Situ","longName":"5914698","preferredDefinition":"An intraductal breast carcinoma characterized by a papillary growth within a large cystic duct. There is no evidence of invasion of the breast parenchyma.: Marked by a tendency to spread, especially into healthy surrounding tissue.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A carcinoma entirely confined to the mammary ducts.  It is also known as DCIS.  There is no evidence of invasion of the basement membrane.  Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Intracystic Papillary Carcinoma","conceptCode":"C7645","definition":"An intraductal breast carcinoma characterized by a papillary growth within a large cystic duct. There is no evidence of invasion of the breast parenchyma.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54D482D5-E3D3-4CB2-E053-F662850A20E3","latestVersionIndicator":"Yes","beginDate":"2017-07-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FE0A-0C22-E053-F662850AD16E","beginDate":"2017-07-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Intracystic papillary carcinoma DCIS","valueDescription":"Intracystic Papillary Breast Carcinoma Ductal Breast Carcinoma In Situ","ValueMeaning":{"publicId":"5914263","version":"1","preferredName":"Intracystic Papillary Breast Carcinoma Ductal Breast Carcinoma In Situ","longName":"5914263","preferredDefinition":"An intraductal breast carcinoma characterized by a papillary growth within a large cystic duct. There is no evidence of invasion of the breast parenchyma.: A carcinoma entirely confined to the mammary ducts.  It is also known as DCIS.  There is no evidence of invasion of the basement membrane.  Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Intracystic Papillary Carcinoma","conceptCode":"C7645","definition":"An intraductal breast carcinoma characterized by a papillary growth within a large cystic duct. There is no evidence of invasion of the breast parenchyma.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B0047C-7D9E-74DF-E053-F662850A6669","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FE14-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Intracystic papillary carcinoma invasive","valueDescription":"Intracystic Papillary Breast Carcinoma Invasive","ValueMeaning":{"publicId":"5914264","version":"1","preferredName":"Intracystic Papillary Breast Carcinoma Invasive","longName":"5914264","preferredDefinition":"An intraductal breast carcinoma characterized by a papillary growth within a large cystic duct. There is no evidence of invasion of the breast parenchyma.: Marked by a tendency to spread, especially into healthy surrounding tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Intracystic Papillary Carcinoma","conceptCode":"C7645","definition":"An intraductal breast carcinoma characterized by a papillary growth within a large cystic duct. There is no evidence of invasion of the breast parenchyma.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B0047C-7E1E-74DF-E053-F662850A6669","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FE1E-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Invasive cribriform carcinoma","valueDescription":"Invasive Cribriform Breast Carcinoma","ValueMeaning":{"publicId":"2581150","version":"1","preferredName":"Invasive Cribriform Breast Carcinoma","longName":"2581150","preferredDefinition":"An invasive adenocarcinoma of the breast with a favorable clinical outcome, characterized by the presence of a sieve-like or cribriform infiltrating pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Cribriform Carcinoma","conceptCode":"C5142","definition":"An invasive adenocarcinoma of the breast with a favorable clinical outcome, characterized by the presence of a sieve-like or cribriform infiltrating pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A0B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FE28-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Invasive ductal carcinoma NOS","valueDescription":"Invasive Ductal Carcinoma, Not Otherwise Specified","ValueMeaning":{"publicId":"2581223","version":"1","preferredName":"Invasive Ductal Carcinoma, Not Otherwise Specified","longName":"2581223","preferredDefinition":"Invasive ductal carcinoma is the most common type of invasive breast carcinoma (accounting for approximately 70% of breast carcinomas). The gross appearance is usually typical with an irregular stellate outline. Microscopically, randomly arranged epithelial elements are seen. When large sheets of malignant cells are present, necrosis may be seen. With adequate tissue sampling, in situ carcinoma can be demonstrated in association with the infiltrating carcinoma. The in situ component is nearly always ductal but occasionally may be lobular or both. --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Carcinoma of No Special Type","conceptCode":"C4194","definition":"A term that refers to a large and heterogeneous group of invasive breast carcinomas that cannot be classified morphologically as any of the special histological types. (WHO 2019)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A54-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FE32-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Invasive Lobular Breast Carcinoma, Tubulolobular Variant","valueDescription":"Invasive Lobular Breast Carcinoma, Tubulolobular Variant","ValueMeaning":{"publicId":"3248498","version":"1","preferredName":"Invasive Lobular Breast Carcinoma, Tubulolobular Variant","longName":"3248498","preferredDefinition":"An invasive lobular carcinoma of the breast, characterized by the presence of neoplastic cells forming small tubular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Lobular Carcinoma, Tubulolobular Variant","conceptCode":"C97053","definition":"An invasive lobular carcinoma of the breast, characterized by the presence of neoplastic cells forming small tubular structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B8531E-180E-F891-E040-BB89AD4324F8","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FE3C-0C22-E053-F662850AD16E","beginDate":"2019-05-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Invasive lobular carcinoma","valueDescription":"Invasive Lobular Breast Carcinoma","ValueMeaning":{"publicId":"2581147","version":"1","preferredName":"Invasive Lobular Breast Carcinoma","longName":"2581147","preferredDefinition":"An infiltrating lobular adenocarcinoma.  The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma.  The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures. --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Lobular Carcinoma","conceptCode":"C7950","definition":"An infiltrating lobular adenocarcinoma of the breast.  The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma.  The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A08-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FE46-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Invasive mammary carcinoma","valueDescription":"Invasive Mammary Carcinoma","ValueMeaning":{"publicId":"5914169","version":"1","preferredName":"Invasive Mammary Carcinoma","longName":"5914169","preferredDefinition":"A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Carcinoma","conceptCode":"C9245","definition":"A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54AF106E-47BA-58A6-E053-F662850A0031","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FE50-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Invasive micropapillary carcinoma","valueDescription":"Invasive Micropapillary Breast Carcinoma","ValueMeaning":{"publicId":"3248497","version":"1","preferredName":"Invasive Micropapillary Breast Carcinoma","longName":"3248497","preferredDefinition":"An invasive breast carcinoma characterized by the presence of clusters of malignant cells located within artifactual clear stromal spaces that resemble vascular spaces.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Micropapillary Carcinoma","conceptCode":"C36084","definition":"An invasive breast carcinoma characterized by the presence of clusters of malignant cells located within artifactual clear stromal spaces that resemble vascular spaces.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B8531E-17EB-F891-E040-BB89AD4324F8","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FE5A-0C22-E053-F662850AD16E","beginDate":"2017-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Invasive mixed carcinoma","valueDescription":"Mixed Histology","ValueMeaning":{"publicId":"3084098","version":"1","preferredName":"Mixed Histology","longName":"3084098","preferredDefinition":"An invasive breast carcinoma containing both ductal and lobular carcinomatous components.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Mixed Carcinoma","conceptCode":"C40347","definition":"An invasive breast carcinoma characterized by the presence of more than one malignant epithelial histologic pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8638268D-A4B9-7AFE-E040-BB89AD43791D","latestVersionIndicator":"Yes","beginDate":"2010-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FE64-0C22-E053-F662850AD16E","beginDate":"2017-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Invasive papillary carcinoma","valueDescription":"Invasive Papillary Breast Carcinoma","ValueMeaning":{"publicId":"5914244","version":"1","preferredName":"Invasive Papillary Breast Carcinoma","longName":"5914244","preferredDefinition":"A ductal breast carcinoma which invades the breast parenchyma.  It is characterized by the formation of papillary structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Papillary Carcinoma","conceptCode":"C36085","definition":"An invasive breast carcinoma characterized by the presence of papillary structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54AE7EF7-3E0E-21B7-E053-F662850AEBEC","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FE6E-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Leiomyosarcoma","valueDescription":"Breast Leiomyosarcoma","ValueMeaning":{"publicId":"5914242","version":"1","preferredName":"Breast Leiomyosarcoma","longName":"5914242","preferredDefinition":"An aggressive malignant smooth muscle neoplasm, arising from the breast.  It is characterized by a proliferation of neoplastic spindle cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Leiomyosarcoma","conceptCode":"C5186","definition":"An aggressive malignant smooth muscle neoplasm, arising from the breast.  It is characterized by a proliferation of neoplastic spindle cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54AE7EF7-3DE6-21B7-E053-F662850AEBEC","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FE78-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Leukemic infiltration","valueDescription":"Breast Leukemic Infiltration","ValueMeaning":{"publicId":"5914340","version":"1","preferredName":"Breast Leukemic Infiltration","longName":"5914340","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.: Malignant hematopoietic cell originating in the clonal proliferation of myeloid or lymphoid precursor that undergoes an aberrant and poorly regulated process of organogenesis resulted in arrested maturation and cell capacity for unlimited self-renewal.: Normal or pathologic migration and accumulation of cells within tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Leukemic Cell","conceptCode":"C25553","definition":"Malignant hematopoietic cell originating in the clonal proliferation of myeloid or lymphoid precursor that undergoes an aberrant and poorly regulated process of organogenesis resulted in arrested maturation and cell capacity for unlimited self-renewal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cellular Infiltration","conceptCode":"C28491","definition":"Normal or pathologic migration and accumulation of cells within tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B27B9C-65B3-56A3-E053-F662850AF8F5","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FE82-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Lipid-rich (lipid secreting) carcinoma","valueDescription":"Lipid-Rich Breast Carcinoma","ValueMeaning":{"publicId":"5914234","version":"1","preferredName":"Lipid-Rich Breast Carcinoma","longName":"5914234","preferredDefinition":"An invasive breast carcinoma characterized by the presence of cytoplasmic neutral lipids in the vast majority of the malignant cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Lipid-Rich Carcinoma","conceptCode":"C40365","definition":"An invasive breast carcinoma characterized by the presence of cytoplasmic neutral lipids in the vast majority of the malignant cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54AE7EF7-3D96-21B7-E053-F662850AEBEC","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FE8C-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Liposarcoma","valueDescription":"Breast Liposarcoma","ValueMeaning":{"publicId":"5914236","version":"1","preferredName":"Breast Liposarcoma","longName":"5914236","preferredDefinition":"A malignant adipose tissue neoplasm of the breast.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Liposarcoma","conceptCode":"C5187","definition":"A liposarcoma that arises from the breast parenchyma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54AE7EF7-3DBE-21B7-E053-F662850AEBEC","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FE96-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Lobular carcinoma","valueDescription":"Lobular Breast Carcinoma","ValueMeaning":{"publicId":"2957350","version":"1","preferredName":"Lobular Breast Carcinoma","longName":"2957350","preferredDefinition":"An adenocarcinoma of the breast arising from the lobules.  This is a relatively uncommon carcinoma, represents approximately 10% of the breast adenocarcinomas and is often bilateral or multifocal.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Lobular Carcinoma","conceptCode":"C3771","definition":"An adenocarcinoma of the breast arising from the lobules.  This is a relatively uncommon carcinoma, represents approximately 10% of the breast adenocarcinomas and is often bilateral or multifocal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"770B3885-67E3-5BD6-E040-BB89AD4371E9","latestVersionIndicator":"Yes","beginDate":"2009-10-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-28","modifiedBy":"ONEDATA","dateModified":"2009-10-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FEA0-0C22-E053-F662850AD16E","beginDate":"2017-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Lymphoma","valueDescription":"Breast Lymphoma","ValueMeaning":{"publicId":"5914446","version":"1","preferredName":"Breast Lymphoma","longName":"5914446","preferredDefinition":"A lymphoma that arises from the breast.  There is no history of extramammary breast lymphoma and ipsilateral axillary lymph node involvement does not exclude the diagnosis of primary breast lymphoma.  Most patients present with a painless breast lump.  The vast majority of cases are B-cell non-Hodgkin lymphomas.  Diffuse large B-cell lymphoma, follicular lymphoma, and extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue are the most common types of primary non-Hodgkin lymphoma of the breast.  Primary Hodgkin lymphoma of the breast is rare.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Lymphoma","conceptCode":"C4671","definition":"A lymphoma that arises from the breast.  There is no history of extramammary breast lymphoma and ipsilateral axillary lymph node involvement does not exclude the diagnosis of primary breast lymphoma.  Most patients present with a painless breast lump.  The vast majority of cases are B-cell non-Hodgkin lymphomas.  Diffuse large B-cell lymphoma, follicular lymphoma, and extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue are the most common types of primary non-Hodgkin lymphoma of the breast.  Primary Hodgkin lymphoma of the breast is rare.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B403C3-8B58-6E80-E053-F662850A461A","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-20","modifiedBy":"ONEDATA","dateModified":"2017-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FEAA-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Lymphovascular invasion","valueDescription":"Lymphatic Invasion","ValueMeaning":{"publicId":"5914232","version":"1","preferredName":"Lymphatic Invasion","longName":"5914232","preferredDefinition":"A term referring to the presence of tumor emboli or tumor masses within lymphatic vessels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphatic Invasion","conceptCode":"C47850","definition":"A term referring to the presence of tumor emboli or tumor masses within lymphatic vessels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54AE7EF7-3D6E-21B7-E053-F662850AEBEC","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FEB4-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Malignant adenomyoepithelioma","valueDescription":"Malignant Breast Adenomyoepithelioma","ValueMeaning":{"publicId":"5943820","version":"1","preferredName":"Malignant Breast Adenomyoepithelioma","longName":"5943820","preferredDefinition":"An adenomyoepithelioma of the breast in which the epithelial, myoepithelial, or both components have undergone malignant transformation.  Such cases may follow an aggressive clinical course, including recurrences and local and distant metastases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Breast Adenomyoepithelioma","conceptCode":"C5143","definition":"An adenomyoepithelioma of the breast in which the epithelial, myoepithelial, or both components have undergone malignant transformation.  Such cases may follow an aggressive clinical course, including recurrences and local and distant metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57D6250A-900F-45A3-E053-F662850A2287","latestVersionIndicator":"Yes","beginDate":"2017-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FEBE-0C22-E053-F662850AD16E","beginDate":"2017-08-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Malignant melanoma of the nipple","valueDescription":"Nipple Malignant Melanoma ","ValueMeaning":{"publicId":"5914424","version":"1","preferredName":"Nipple Malignant Melanoma ","longName":"5914424","preferredDefinition":"The pigmented protuberance on the surface of the breast through which milk is drawn from the breast.: Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nipple","conceptCode":"C12299","definition":"The pigmented protuberance on the surface of the breast through which milk is drawn from the breast.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Malignant","conceptCode":"C14143","definition":"Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54C1F10B-4730-3474-E053-F662850AD024","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FEC8-0C22-E053-F662850AD16E","beginDate":"2017-07-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Medullary carcinoma","valueDescription":"Medullary Breast Carcinoma","ValueMeaning":{"publicId":"2581146","version":"1","preferredName":"Medullary Breast Carcinoma","longName":"2581146","preferredDefinition":"An infiltrating breast carcinoma distinguished by its allegedly good prognosis. Medullary breast carcinoma is uncommon, accounting for fewer than 1% of all infiltrating breast carcinomas. Grossly, this is a well circumscribed tumor, with soft cut surface and often of considerable size.  Microscopically the predominant growth pattern is syncytial with broad anastomosing bands or sheets of malignant cells. The sheets of malignant cells are associated with a marked lymphocytic and plasmacytic infiltrate.  --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Medullary Carcinoma","conceptCode":"C9119","definition":"An infiltrating breast carcinoma with a relatively favorable prognosis.  It is an uncommon carcinoma, accounting for less than 1% of all infiltrating breast carcinomas.  It is well circumscribed, with soft cut surface and often of considerable size.  Microscopically, the predominant growth pattern is syncytial with broad anastomosing bands or sheets of malignant cells.  The malignant cells are round with abundant cytoplasm and vesicular nuclei.  The sheets of malignant cells are associated with a marked lymphoplasmacytic infiltrate.  Glandular or tubular structures are absent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A07-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-09","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FED2-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Metaplastic carcinoma","valueDescription":"Metaplastic Breast Carcinoma","ValueMeaning":{"publicId":"5914432","version":"1","preferredName":"Metaplastic Breast Carcinoma","longName":"5914432","preferredDefinition":"A group of invasive breast carcinomas characterized by the presence of an adenocarcinomatous component which is admixed with a dominant component that is composed of squamous cells, spindle cells, or mesenchymal cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Metaplastic Carcinoma","conceptCode":"C5164","definition":"A group of invasive breast carcinomas characterized by the presence of an adenocarcinomatous component which is admixed with a dominant component that is composed of squamous cells, spindle cells, or mesenchymal cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54C27117-2245-44E6-E053-F662850A718A","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FEDC-0C22-E053-F662850AD16E","beginDate":"2017-07-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Metastasis to an intramammary node","valueDescription":"Metastasis To Internal Mammary Lymph Node ","ValueMeaning":{"publicId":"5914433","version":"1","preferredName":"Metastasis To Internal Mammary Lymph Node ","longName":"5914433","preferredDefinition":"The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.: Used as a function word to indicate direction, purpose, or movement.: Any of the lymph nodes of the breast located under the ribcage, near the sternum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastasis","conceptCode":"C19151","definition":"The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Internal Mammary Lymph Node","conceptCode":"C32853","definition":"Any of the lymph nodes of the breast located under the ribcage, near the sternum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54C27117-226A-44E6-E053-F662850A718A","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FEE6-0C22-E053-F662850AD16E","beginDate":"2017-07-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Metastatic cancer to the breast","valueDescription":"Metastatic Malignant Neoplasm in the Breast","ValueMeaning":{"publicId":"5914338","version":"1","preferredName":"Metastatic Malignant Neoplasm in the Breast","longName":"5914338","preferredDefinition":"The spread of a malignant neoplasm to the breast. This may be from a primary breast malignant neoplasm on the opposite side, or from a malignant neoplasm at a distant site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Malignant Neoplasm in the Breast","conceptCode":"C7511","definition":"The spread of a malignant neoplasm to the breast. This may be from a primary breast malignant neoplasm on the opposite side, or from a malignant neoplasm at a distant site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B27B9C-655D-56A3-E053-F662850AF8F5","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FEF0-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Metastatic cancer to the breast from the colon","valueDescription":"Colon Metastatic Malignant Neoplasm To Breast ","ValueMeaning":{"publicId":"5914336","version":"1","preferredName":"Colon Metastatic Malignant Neoplasm To Breast ","longName":"5914336","preferredDefinition":"The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion.: A malignant tumor that has spread from its original (primary) site of growth to another site close to or distant from the primary site.: Used as a function word to indicate direction, purpose, or movement.: One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colon","conceptCode":"C12382","definition":"The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Metastatic Malignant Neoplasm","conceptCode":"C36263","definition":"A malignant tumor that has spread from its original (primary) site of growth to another site close to or distant from the primary site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B27B9C-6535-56A3-E053-F662850AF8F5","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FEFA-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Metastatic cancer to the breast from the lung","valueDescription":"Lung Metastatic Malignant Neoplasm To Breast ","ValueMeaning":{"publicId":"5914376","version":"1","preferredName":"Lung Metastatic Malignant Neoplasm To Breast ","longName":"5914376","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.: A malignant tumor that has spread from its original (primary) site of growth to another site close to or distant from the primary site.: Used as a function word to indicate direction, purpose, or movement.: One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Metastatic Malignant Neoplasm","conceptCode":"C36263","definition":"A malignant tumor that has spread from its original (primary) site of growth to another site close to or distant from the primary site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B2B673-2001-56AE-E053-F662850A2B0C","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FF04-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Metastatic cancer to the breast from the ovary","valueDescription":"Ovary Metastatic Malignant Neoplasm To Breast ","ValueMeaning":{"publicId":"5914425","version":"1","preferredName":"Ovary Metastatic Malignant Neoplasm To Breast ","longName":"5914425","preferredDefinition":"One of the paired female reproductive glands containing the ova or germ cells; the ovary's stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova.: A malignant tumor that has spread from its original (primary) site of growth to another site close to or distant from the primary site.: Used as a function word to indicate direction, purpose, or movement.: One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovary","conceptCode":"C12404","definition":"One of the paired female reproductive glands containing the ova or germ cells; the ovary's stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Metastatic Malignant Neoplasm","conceptCode":"C36263","definition":"A malignant tumor that has spread from its original (primary) site of growth to another site close to or distant from the primary site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54C1F10B-4755-3474-E053-F662850AD024","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FF0E-0C22-E053-F662850AD16E","beginDate":"2017-07-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Metastatic sarcoma to the breast","valueDescription":"Metastatic Sarcoma To Breast ","ValueMeaning":{"publicId":"5914434","version":"1","preferredName":"Metastatic Sarcoma To Breast ","longName":"5914434","preferredDefinition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.: A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.: Used as a function word to indicate direction, purpose, or movement.: One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Sarcoma","conceptCode":"C9118","definition":"A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54C27117-228F-44E6-E053-F662850A718A","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FF18-0C22-E053-F662850AD16E","beginDate":"2017-07-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Microcalcifications associated with ductal carcinoma in situ","valueDescription":"Microcalcification Associated With Ductal Breast Carcinoma In Situ","ValueMeaning":{"publicId":"5914298","version":"1","preferredName":"Microcalcification Associated With Ductal Breast Carcinoma In Situ","longName":"5914298","preferredDefinition":"Tiny deposits of calcium in tissue.  In the breast they can be seen using mammography, and if found in clusters may be indicative of breast cancer.: Joined in some kind of relationship.: Used to indicate the presence of something or someone.: A carcinoma entirely confined to the mammary ducts.  It is also known as DCIS.  There is no evidence of invasion of the basement membrane.  Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microcalcification","conceptCode":"C8433","definition":"Tiny deposits of calcium in tissue.  In the breast they can be seen using mammography, and if found in clusters may be indicative of breast cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Associated","conceptCode":"C25281","definition":"Joined in some kind of relationship.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B1EEE3-C96D-0E6F-E053-F662850A3AD8","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FF22-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Microinvasive carcinoma","valueDescription":"Microinvasive Breast Carcinoma","ValueMeaning":{"publicId":"5937396","version":"1","preferredName":"Microinvasive Breast Carcinoma","longName":"5937396","preferredDefinition":"Ductal carcinoma in situ of the breast with minimal stromal invasion.  Lymph node involvement is uncommon and the prognosis is generally good.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microinvasive Breast Carcinoma","conceptCode":"C40374","definition":"Invasive breast carcinoma measuring 1 mm or less in size.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5786ADA0-5D8D-37FD-E053-F662850A22EE","latestVersionIndicator":"Yes","beginDate":"2017-08-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FF2C-0C22-E053-F662850AD16E","beginDate":"2017-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Mixed epithelial mesenchymal metaplastic carcinoma","valueDescription":"Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma","ValueMeaning":{"publicId":"2577127","version":"1","preferredName":"Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma","longName":"2577127","preferredDefinition":"An invasive breast carcinoma characterized by the presence of a mesenchymal cellular component. The mesenchymal cellular component ranges from cartilaginous and osseous, to purely sarcomatous.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma","conceptCode":"C40364","definition":"An invasive breast carcinoma characterized by the presence of a mesenchymal cellular component.  The mesenchymal cellular component ranges from cartilaginous and osseous, to purely sarcomatous.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA54-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FF36-0C22-E053-F662850AD16E","beginDate":"2017-08-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Mucinous (colloid) carcinoma","valueDescription":"Breast Mucinous Carcinoma","ValueMeaning":{"publicId":"2577124","version":"1","preferredName":"Breast Mucinous Carcinoma","longName":"2577124","preferredDefinition":"An invasive adenocarcinoma of the breast characterized by the presence of islands of small and uniform cells, surrounded by large amounts of mucin.  Pure mucinous breast carcinomas generally have a favorable prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Mucinous Carcinoma","conceptCode":"C9131","definition":"An invasive adenocarcinoma of the breast characterized by the presence of islands of small and uniform cells, surrounded by large amounts of mucin.  Pure mucinous breast carcinomas generally have a favorable prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA51-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"TAYLORT","dateModified":"2017-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FF40-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Mucoepidermoid carcinoma","valueDescription":"Mucoepidermoid Carcinoma","ValueMeaning":{"publicId":"3704622","version":"1","preferredName":"Mucoepidermoid Carcinoma","longName":"3704622","preferredDefinition":"A carcinoma morphologically characterized the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation. It can occur in several anatomic sites, including parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. It is classified as low or high grade.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucoepidermoid Carcinoma","conceptCode":"C3772","definition":"A carcinoma morphologically characterized the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation. It can occur in several anatomic sites, including parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. It is classified as low or high grade.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3B3E-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FF4A-0C22-E053-F662850AD16E","beginDate":"2017-08-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Neoplasm of the mammary skin","valueDescription":"Mammary Skin Neoplasm ","ValueMeaning":{"publicId":"5914428","version":"1","preferredName":"Mammary Skin Neoplasm ","longName":"5914428","preferredDefinition":"Having to do with the breast.: A benign or malignant tumor involving the skin.  Representative examples of benign skin neoplasms include the benign melanocytic skin nevus, acanthoma, sebaceous adenoma, sweat gland adenoma, lipoma, hemangioma, fibroma, and benign fibrous histiocytoma.  Representative examples of malignant skin neoplasms include basal cell carcinoma, squamous cell carcinoma, melanoma, and Kaposi sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mammary","conceptCode":"C43595","definition":"Having to do with the breast.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Skin Neoplasm","conceptCode":"C3372","definition":"A benign, intermediate, or malignant neoplasm involving the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54C27117-21F5-44E6-E053-F662850A718A","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FF54-0C22-E053-F662850AD16E","beginDate":"2017-07-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Neuroendocrine tumor well differentiated","valueDescription":"Breast Neuroendocrine Neoplasm Well Differentiated","ValueMeaning":{"publicId":"5943822","version":"1","preferredName":"Breast Neuroendocrine Neoplasm Well Differentiated","longName":"5943822","preferredDefinition":"A neoplasm that arises from the breast and is composed of cells of neuroendocrine origin.  Most cases are neuroendocrine carcinomas.  Primary carcinoid tumors of the breast are very rare.: Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Neuroendocrine Neoplasm","conceptCode":"C5169","definition":"A neoplasm that arises from the breast and is composed of cells exhibiting neuroendocrine differentiation. It is classified as neuroendocrine carcinoma or neuroendocrine tumor G1 and neuroendocrine tumor G2. Most cases are neuroendocrine carcinomas.  Primary neuroendocrine tumors in the breast are very rare.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Well Differentiated","conceptCode":"C14171","definition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57D6250A-9036-45A3-E053-F662850A2287","latestVersionIndicator":"Yes","beginDate":"2017-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FF5E-0C22-E053-F662850AD16E","beginDate":"2017-08-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Non-Hodgkin lymphoma","valueDescription":"Non-Hodgkin Breast Lymphoma","ValueMeaning":{"publicId":"5914430","version":"1","preferredName":"Non-Hodgkin Breast Lymphoma","longName":"5914430","preferredDefinition":"A non-Hodgkin lymphoma that arises from the breast.  There is no history of extramammary breast non-Hodgkin lymphoma and ipsilateral axillary lymph node involvement does not exclude the diagnosis of primary breast non-Hodgkin lymphoma.  Most patients present with a painless breast lump.  The vast majority of cases are B-cell non-Hodgkin lymphomas.  Diffuse large B-cell lymphoma, follicular lymphoma, and extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue are the most common types of primary non-Hodgkin lymphoma of the breast.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Non-Hodgkin Lymphoma","conceptCode":"C5181","definition":"A non-Hodgkin lymphoma that arises from the breast.  There is no history of extramammary breast non-Hodgkin lymphoma and ipsilateral axillary lymph node involvement does not exclude the diagnosis of primary breast non-Hodgkin lymphoma.  Most patients present with a painless breast lump.  The vast majority of cases are B-cell non-Hodgkin lymphomas.  Diffuse large B-cell lymphoma, follicular lymphoma, and extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue are the most common types of primary non-Hodgkin lymphoma of the breast.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54C27117-221D-44E6-E053-F662850A718A","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FF68-0C22-E053-F662850AD16E","beginDate":"2017-07-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"None","valueDescription":"None","ValueMeaning":{"publicId":"2577064","version":"1","preferredName":"None","longName":"2577064","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA15-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FF72-0C22-E053-F662850AD16E","beginDate":"2017-08-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Not present","valueDescription":"Absent","ValueMeaning":{"publicId":"2566329","version":"1","preferredName":"Absent","longName":"2566329","preferredDefinition":"Not existing in a specified place at a specified time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Absent","conceptCode":"C48190","definition":"Not existing in a specified place at a specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D026-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-05","endDate":null,"createdBy":"CHANGM","dateCreated":"2003-08-05","modifiedBy":"SOKKERL","dateModified":"2019-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FF7C-0C22-E053-F662850AD16E","beginDate":"2017-08-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Oncocytic carcinoma","valueDescription":"Oncocytic Breast Carcinoma","ValueMeaning":{"publicId":"5340877","version":"1","preferredName":"Oncocytic Breast Carcinoma","longName":"5340877","preferredDefinition":"A rare breast adenocarcinoma characterized by the presence of neoplastic oncocytic cells.  The oncocytic cells comprise more than 70 percent of the malignant cellular population.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Oncocytic Carcinoma","conceptCode":"C40366","definition":"A rare breast adenocarcinoma characterized by the presence of malignant oncocytic cells. The oncocytic cells comprise more than 70 percent of the malignant cellular population.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"375CD547-5955-BFE6-E050-BB89AD436459","latestVersionIndicator":"Yes","beginDate":"2016-07-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-07-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FF86-0C22-E053-F662850AD16E","beginDate":"2017-08-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Osteosarcoma","valueDescription":"Breast Extraskeletal Osteosarcoma","ValueMeaning":{"publicId":"5914427","version":"1","preferredName":"Breast Extraskeletal Osteosarcoma","longName":"5914427","preferredDefinition":"An osteosarcoma arising from the breast tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Extraskeletal Osteosarcoma","conceptCode":"C5189","definition":"An osteosarcoma arising from the breast tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54C27117-21D0-44E6-E053-F662850A718A","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FF90-0C22-E053-F662850AD16E","beginDate":"2017-07-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2753633","version":"1","preferredName":"Other","longName":"2753633v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E5169E1-5EBA-184A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-28","modifiedBy":"CLOHNES","dateModified":"2023-07-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FF9A-0C22-E053-F662850AD16E","beginDate":"2017-08-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Paget's disease of the nipple","valueDescription":"Paget Disease of the Nipple","ValueMeaning":{"publicId":"3669425","version":"1","preferredName":"Paget Disease of the Nipple","longName":"3669425","preferredDefinition":"A malignant epithelial cellular proliferation characterized by the presence of atypical cells with large nuclei and abundant pale cytoplasm within the squamous epithelium of the nipple.  In almost all cases there is an underlying intraductal breast carcinoma or intraductal and invasive carcinoma.  The skin changes range from redness to eczematous appearance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nipple Paget Disease","conceptCode":"C3301","definition":"A malignant epithelial cellular proliferation characterized by the presence of atypical cells with large nuclei and abundant pale cytoplasm within the squamous epithelium of the nipple.  In almost all cases there is an underlying intraductal breast carcinoma or intraductal and invasive carcinoma.  The skin changes range from redness to eczematous appearance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-7334-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FFA4-0C22-E053-F662850AD16E","beginDate":"2017-07-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Papillary carcinoma","valueDescription":"Papillary Breast Carcinoma","ValueMeaning":{"publicId":"2581145","version":"1","preferredName":"Papillary Breast Carcinoma","longName":"2581145","preferredDefinition":"A malignant breast neoplasm characterized by the formation of irregular, finger-like projections of fibrous stroma covered with neoplastic epithelial cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Papillary Carcinoma","conceptCode":"C9134","definition":"A breast carcinoma characterized by the formation of irregular, finger-like projections of fibrous stroma covered with neoplastic epithelial cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A06-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-09","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FFAE-0C22-E053-F662850AD16E","beginDate":"2017-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Papillary carcinoma in situ","valueDescription":"Papillary Carcinoma In Situ","ValueMeaning":{"publicId":"3251532","version":"1","preferredName":"Papillary Carcinoma In Situ","longName":"3251532","preferredDefinition":"An epithelial neoplasm with a papillary growth pattern in which the malignant cells are confined to the epithelium, without evidence of invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Carcinoma In Situ","conceptCode":"C65163","definition":"An epithelial neoplasm with a papillary growth pattern in which the malignant cells are confined to the epithelium, without evidence of invasion.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A766EF05-0A2C-69EE-E040-BB89AD437928","latestVersionIndicator":"Yes","beginDate":"2011-07-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FFB8-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Phyllodes tumor - borderline","valueDescription":"Borderline Breast Phyllodes Tumor","ValueMeaning":{"publicId":"5914436","version":"1","preferredName":"Borderline Breast Phyllodes Tumor","longName":"5914436","preferredDefinition":"A phyllodes tumor of the breast characterized by the presence of intermediate features and a stroma which usually resembles low grade fibrosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Breast Phyllodes Tumor","conceptCode":"C5316","definition":"A phyllodes tumor of the breast characterized by the presence of intermediate features and a stroma which usually resembles low grade fibrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B27B9C-6655-56A3-E053-F662850AF8F5","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FFC2-0C22-E053-F662850AD16E","beginDate":"2017-07-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Plasmacytoma","valueDescription":"Breast Plasmacytoma","ValueMeaning":{"publicId":"5914439","version":"1","preferredName":"Breast Plasmacytoma","longName":"5914439","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.: A malignant (clonal) proliferation of plasma cells that are cytologically and immunophenotypically identical to those of plasma cell myeloma, but manifest a localized osseous or extraosseous growth pattern. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Plasmacytoma","conceptCode":"C9349","definition":"A malignant neoplasm characterized by the presence of a monoclonal population of plasma cells forming a tumor mass.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B27B9C-66A2-56A3-E053-F662850AF8F5","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FFD6-0C22-E053-F662850AD16E","beginDate":"2017-07-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Pleomorphic carcinoma","valueDescription":"Pleomorphic Breast Carcinoma","ValueMeaning":{"publicId":"5945711","version":"1","preferredName":"Pleomorphic Breast Carcinoma","longName":"5945711","preferredDefinition":"A rare, aggressive, high grade invasive ductal carcinoma, not otherwise specified.  It is characterized by the presence of pleomorphic and bizarre malignant cells that constitute more than 50 percent of the malignant cellular infiltrate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Pleomorphic Carcinoma","conceptCode":"C5161","definition":"A rare, aggressive, high grade invasive ductal carcinoma, not otherwise specified.  It is characterized by the presence of pleomorphic and bizarre malignant cells that constitute more than 50 percent of the malignant cellular infiltrate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57F8F28F-679A-1DD3-E053-F662850A4FC7","latestVersionIndicator":"Yes","beginDate":"2017-08-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FFE0-0C22-E053-F662850AD16E","beginDate":"2017-08-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Phyllodes tumor - malignant","valueDescription":"Malignant Breast Phyllodes Tumor","ValueMeaning":{"publicId":"5914441","version":"1","preferredName":"Malignant Breast Phyllodes Tumor","longName":"5914441","preferredDefinition":"A phyllodes tumor of the breast characterized by infiltrative margins and a sarcomatous stromal component.  The sarcomatous stroma usually displays features of fibrosarcoma.  Liposarcomatous, osteosarcomatous, or rhabdomyosarcomatous elements may also be present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Breast Phyllodes Tumor","conceptCode":"C4504","definition":"A phyllodes tumor of the breast characterized by infiltrative margins and a sarcomatous stromal component.  The sarcomatous stroma usually displays features of fibrosarcoma.  Liposarcomatous, osteosarcomatous, or rhabdomyosarcomatous elements may also be present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B27B9C-66CA-56A3-E053-F662850AF8F5","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FFCC-0C22-E053-F662850AD16E","beginDate":"2017-07-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Pleomorphic undifferentiated sarcoma","valueDescription":"Metastatic Undifferentiated Pleomorphic Sarcoma","ValueMeaning":{"publicId":"5914444","version":"1","preferredName":"Metastatic Undifferentiated Pleomorphic Sarcoma","longName":"5914444","preferredDefinition":"An undifferentiated pleomorphic sarcoma that has spread to other anatomical sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Undifferentiated Pleomorphic Sarcoma","conceptCode":"C4926","definition":"An undifferentiated pleomorphic sarcoma that has spread to other anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B27B9C-6717-56A3-E053-F662850AF8F5","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FFEA-0C22-E053-F662850AD16E","beginDate":"2017-07-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Sebaceous carcinoma","valueDescription":"Sebaceous Breast Carcinoma","ValueMeaning":{"publicId":"5943826","version":"1","preferredName":"Sebaceous Breast Carcinoma","longName":"5943826","preferredDefinition":"A very rare breast adenocarcinoma with sebaceous differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Sebaceous Carcinoma","conceptCode":"C40369","definition":"A very rare breast adenocarcinoma with sebaceous differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57D6250A-90BB-45A3-E053-F662850A2287","latestVersionIndicator":"Yes","beginDate":"2017-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FFF4-0C22-E053-F662850AD16E","beginDate":"2017-08-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Secretory carcinoma","valueDescription":"Secretory Breast Carcinoma","ValueMeaning":{"publicId":"2581224","version":"1","preferredName":"Secretory Breast Carcinoma","longName":"2581224","preferredDefinition":"A rare, low grade invasive adenocarcinoma of the breast characterized by the presence of cells that secrete milk-like material. Morphologically, it usually appears as a circumscribed lesion, composed of cystic spaces, tubular structures, and solid areas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Secretory Carcinoma","conceptCode":"C4189","definition":"A rare, low grade invasive adenocarcinoma of the breast characterized by the presence of cells that secrete milk-like material. Morphologically, it usually appears as a circumscribed lesion, composed of cystic spaces, tubular structures, and solid areas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A55-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3E-FFFE-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Signet ring cell carcinoma","valueDescription":"Signet Ring Cell Breast Carcinoma","ValueMeaning":{"publicId":"5914231","version":"1","preferredName":"Signet Ring Cell Breast Carcinoma","longName":"5914231","preferredDefinition":"An invasive breast adenocarcinoma characterized by the presence of malignant epithelial cells with signet ring appearance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Signet Ring Cell Carcinoma","conceptCode":"C5175","definition":"An invasive breast adenocarcinoma characterized by the presence of malignant epithelial cells with signet ring appearance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54AE7EF7-3D3C-21B7-E053-F662850AEBEC","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3F-0008-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Small cell carcinoma","valueDescription":"Breast Small Cell Carcinoma","ValueMeaning":{"publicId":"5628144","version":"1","preferredName":"Breast Small Cell Carcinoma","longName":"5628144","preferredDefinition":"A small cell carcinoma that arises from the breast.  The morphologic and immunohistochemical features are identical to those seen in the small cell carcinoma of the lung.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Small Cell Neuroendocrine Carcinoma","conceptCode":"C6760","definition":"A poorly differentiated neuroendocrine carcinoma that arises from the breast.  It is characterized by the presence of small neuroendocrine cells and high mitotic activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"46007103-3C75-3D08-E053-F662850A8921","latestVersionIndicator":"Yes","beginDate":"2017-01-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-01-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3F-0012-0C22-E053-F662850AD16E","beginDate":"2017-08-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Squamous cell carcinoma","valueDescription":"Squamous Cell Breast Carcinoma","ValueMeaning":{"publicId":"5914438","version":"1","preferredName":"Squamous Cell Breast Carcinoma","longName":"5914438","preferredDefinition":"A rare carcinoma that arises from the breast parenchyma and is entirely composed of squamous cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Squamous Cell Carcinoma","conceptCode":"C5177","definition":"A rare carcinoma that arises from the breast parenchyma and is entirely composed of squamous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B27B9C-667D-56A3-E053-F662850AF8F5","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3F-001C-0C22-E053-F662850AD16E","beginDate":"2017-07-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Squamous cell carcinoma of the nipple","valueDescription":"Nipple Squamous Cell Carcinoma ","ValueMeaning":{"publicId":"5914442","version":"1","preferredName":"Nipple Squamous Cell Carcinoma ","longName":"5914442","preferredDefinition":"The pigmented protuberance on the surface of the breast through which milk is drawn from the breast.: A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nipple","conceptCode":"C12299","definition":"The pigmented protuberance on the surface of the breast through which milk is drawn from the breast.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B27B9C-66EF-56A3-E053-F662850AF8F5","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3F-0026-0C22-E053-F662850AD16E","beginDate":"2017-07-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Squamous cell carcinoma with spindle cell variant","valueDescription":"Squamous Cell Breast Carcinoma, Spindle Cell Variant","ValueMeaning":{"publicId":"5937356","version":"1","preferredName":"Squamous Cell Breast Carcinoma, Spindle Cell Variant","longName":"5937356","preferredDefinition":"A squamous cell carcinoma that arises from the breast parenchyma and is characterized by the presence of spindle-shaped malignant cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Squamous Cell Carcinoma, Spindle Cell Variant","conceptCode":"C40358","definition":"A squamous cell carcinoma that arises from the breast parenchyma and is characterized by the presence of spindle-shaped malignant cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57860B48-EB03-7E76-E053-F662850A3DAA","latestVersionIndicator":"Yes","beginDate":"2017-08-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3F-0030-0C22-E053-F662850AD16E","beginDate":"2017-08-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Tubular carcinoma","valueDescription":"Tubular Breast Carcinoma","ValueMeaning":{"publicId":"2577121","version":"1","preferredName":"Tubular Breast Carcinoma","longName":"2577121","preferredDefinition":"A melanoma of the skin characterized by single cell infiltration of the papillary dermis by atypical melanocytes, in a background of lentigo maligna changes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Tubular Carcinoma","conceptCode":"C9135","definition":"An invasive adenocarcinoma of the breast with a favorable prognosis.  It is composed of tubular structures lined by a single layer of epithelium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA4E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-09","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"964DCA3F-003A-0C22-E053-F662850AD16E","beginDate":"2017-07-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","deletedIndicator":"No"},{"value":"Occult carcinoma presenting with axillary lymph node metastases","valueDescription":"Occult Breast Carcinoma Presenting With Axillary Lymph Node Metastases","ValueMeaning":{"publicId":"5914339","version":"1","preferredName":"Occult Breast Carcinoma Presenting With Axillary Lymph Node Metastases","longName":"5914339","preferredDefinition":"Occult Breast Carcinoma Presenting With Axillary Lymph Node Metastases","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54B27B9C-6582-56A3-E053-F662850AF8F5","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-07-19","modifiedBy":"DWARZEL","dateModified":"2018-03-16","changeDescription":"Removed spaces in name and definiton","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A49414A9-A743-65CF-E053-F662850A369E","beginDate":"2020-05-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-01","modifiedBy":"ONEDATA","dateModified":"2020-05-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"964DCA3E-FCEF-0C22-E053-F662850AD16E","latestVersionIndicator":"Yes","beginDate":"2019-11-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"HARTLEYG","dateModified":"2020-06-17","changeDescription":"Created for CDSIC aligned NCI Standard CRFs. ghd Added PV. AK 2020-5-1  Released. AK 2020-6-4","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6921971","version":"1","longName":"CDISC Aligned Collection CDEs","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"7318345","version":"1","longName":"Microscopic Pathology - CDISC Aligned","context":"NCI Standards"},{"publicId":"7318344","version":"1","longName":"Pathology - CDISC Aligned","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Invasive component, breast","type":"Preferred Question Text","description":"Invasive component, breast","url":null,"context":"NCI Standards"},{"name":"CDISC Aligned NCI Standard Equivalent CDE","type":"CDISC Note","description":"This data element is to be used for CDISC aligned data collection in place of CDE 5914586 from the original NCI Standard CRF Template.","url":null,"context":"NCI Standards"}],"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"964DCDD9-9058-0C18-E053-F662850ADD27","latestVersionIndicator":"Yes","beginDate":"2019-11-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"GDEEN","dateModified":"2023-02-13","changeDescription":"Released. AK 2020-6-4; Created for CDSIC aligned NCI Standard CRFs. ghd","administrativeNotes":"02.13.23_Set Reg Status to Standard for all CDISC Aligned content_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}